TevaFrom TevaU.S. Faces Shortage of Childhood Cancer DrugFDA Approves Biosimilar, But it Comes with a Severe Label WarningTeva’s Generic EpiPen First to Gain FDA ApprovalTop 10 Patent Cliffs of 2017Teva Signs Deal on Metered-Dose Marijuana InhalerTeva Signs Deal on Metered-Dose Marijuana InhalerTeva Expects to Pay $500M+ for Bribery AllegationsTeva Expects to Pay $500M+ for Bribery AllegationsFDA Pauses Regeneron/Teva Painkiller StudyIndustry Collaboration Sheds Light on SerializationIndustry Collaboration Sheds Light on SerializationPackets a prescription to savingsPage 1 of 1
